Managing HER2-positive breast cancer

Bookmark and Share
Published: 16 Feb 2021
Views: 438
Rating:
Save
Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA

Prof Monica Morrow speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about managing patients with HER2-positive breast cancer.

She speaks about the benefits of neo-adjuvant therapies for these patients, giving her practical advice for management strategies and discussing recent relevant research.